Pharminent

Allergan, Adamas introduce new Namzaric dosage strengths in US to treat Alzheimer’s disease

Allergan plc, a leading global pharmaceutical company, and Adamas Pharmaceuticals, Inc. announced that all four dosage strengths of Namzaric (memantine and donepezil hydrochlorides) extended─release http://pharmabiz.com/ArticleDetails.aspx?aid=97652&sid=2

Filed under: Alzheimer’s